Jean Lopategui MD

Medical Director, Molecular Pathology and Clinical Cytogenetics

Jean Lopategui, MD is director of Molecular Pathology and Clinical Cytogenetics and the director of the Molecular Genetic Pathology Fellowship Program at Cedars-Sinai.

Dr. Lopategui’s primary areas of research interest include hematology/oncology molecular profiling, pharmacogenomics and engineered antibodies in cancer therapy.  Dr. Lopategui has participated in molecular and personalized medicine advances including the development of a multiplex RT-PCR assay using a novel dual-probe technique, and a pilot project for genetic disease screening in the Los Angeles Persian Jewish community.  He lectures nationally and internationally on personalized medicine and is an active member of the College of American Pathologists Pharmacogenomics Committee.  Additionally, Dr. Lopategui has been interviewed by PBS for the Nova television series, the New York Times’ Science section and CBS news for pieces on personalized medicine.

Dr. Lopategui earned his medical degree from University of Marseilles Medical School in France and completed his residency in anatomic and clinical pathology at Georgetown University Hospital in Washington, DC and at Tufts University in Boston.  After a year of research in molecular pathology at Tufts, Dr. Lopategui completed a fellowship in hematopathology under the mentorship of Dr. Henry Rappaport at the City of Hope National Medical Center in Duarte, California.  Dr. Lopategui is board certified in anatomic pathology and clinical pathology, with subspecialty certification in molecular genetic pathology and hematology.